Effects of alternative maternal micronutrient supplements on low birth weight in rural Nepal: double blind randomised community trial
Parul Christian, Subarna K Khatry, Joanne Katz, Elizabeth K Pradhan, Steven C LeClerq, Sharada Ram Shrestha, Ramesh K Adhikari, Alfred Sommer, Keith P West Jr
BMJ · 2003 · DOI: 10.1136/bmj.326.7389.571
Countries: Nepal
What Was Studied
This double-blind, cluster-randomised controlled community trial, conducted in Sarlahi district (south-eastern Terai plains, Nepal) from December 1998 to April 2001, tested whether daily antenatal micronutrient supplementation could reduce low birth weight. 426 geographic sectors (75-150 households each, spanning 30 village development communities) were randomised to one of five regimens: folic acid alone, folic acid-iron, folic acid-iron-zinc, a 14-nutrient multiple micronutrient supplement, or vitamin A alone (control) — all pregnant women additionally received vitamin A. Fieldworkers screened 36,083 women of reproductive age and enrolled 4,926 pregnant women; 4,130 live-born infants were weighed, measured for length, and had head/chest circumference recorded within 72 hours of birth (median compliance with supplementation was 88%).
What They Found
Folic acid alone had no effect on birth weight. Folic acid-iron increased mean birth weight by 37 g (95% CI -16 g to 90 g) and reduced low birth weight (<2500 g) from 43% in the control group to 34% — a 16% relative risk reduction (RR 0.84, 95% CI 0.72 to 0.99). The 14-nutrient multiple micronutrient supplement increased birth weight by 64 g (95% CI 12 g to 115 g) and reduced low birth weight by 14% (RR 0.86, 95% CI 0.74 to 0.99) — statistically indistinguishable from folic acid-iron alone, meaning the additional 11 micronutrients conferred no extra benefit. Folic acid-iron-zinc showed no significant effect on any birth size measure. None of the four regimens reduced preterm birth (all relative risks approximately 1.0). The authors calculated that 11 women would need to be supplemented with folic acid-iron (or 12 with multiple micronutrients) to avert one low-birthweight birth.
What This Means for Nepal
This landmark Nepal-based trial has directly shaped global antenatal supplementation policy, including guidance to prioritise iron-folic acid over broader multiple micronutrient supplements in high-anaemia settings. Nepal's women still have a 34% anaemia prevalence and roughly 15% of babies are born with low birth weight nationally (NDHS 2022) — both far below the 43% low-birth-weight rate this trial found in Sarlahi at baseline, showing real but incomplete progress since the late 1990s. FCHVs (~50,400 nationwide), who already distribute iron and vitamin A as part of their nutrition mandate, remain the delivery backbone for antenatal micronutrients, especially in Madhesh Province — where Sarlahi is located and where facility density is lowest and fertility highest nationally. Concrete recommendation: the Family Welfare Division/DoHS should continue prioritising and adequately budgeting simple iron-folic acid supplementation (rather than costlier multi-micronutrient formulations) within antenatal care protocols, while directing FCHV-led compliance support — modelled on this trial's twice-weekly household visits that achieved 88% adherence — toward high-burden districts in Madhesh Province.
Contextualisation
Nepal's own national data show 34% of women of reproductive age are anaemic and roughly 15% of babies are born with low birth weight (NDHS 2022) — this trial, conducted in Sarlahi district (Madhesh Province), is the foundational Nepal-based evidence showing that simple antenatal folic acid-iron supplementation, not costlier multi-micronutrient formulas, can meaningfully reduce low birth weight. Because FCHVs (~50,400 nationwide) already distribute iron and vitamin A as part of their routine nutrition mandate, these findings map directly onto Nepal's existing community health infrastructure rather than requiring a new delivery system.